Patents by Inventor Michael Bowe

Michael Bowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bromocriptine Formulations
    Publication number: 20190343833
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: April 24, 2019
    Publication date: November 14, 2019
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • ANTIBODY FORMULATIONS
    Publication number: 20190338036
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: April 24, 2019
    Publication date: November 7, 2019
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • CONTROLLED-RELEASE SOLID DOSAGE FORMS OF MESALAMINE
    Publication number: 20190231699
    Abstract: Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-released solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention related to a methods of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowl disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
    Type: Application
    Filed: August 31, 2018
    Publication date: August 1, 2019
    Applicant: Santarus, Inc.
    Inventors: Craig Michael Bowe, John Christopher Carter, Dana Elaine Moseson, Stephen Paul Levine
  • ANTI-VLA1 (CD49A) ANTIBODY PHARMACEUTICAL COMPOSITIONS
    Publication number: 20190194331
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: December 20, 2018
    Publication date: June 27, 2019
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • Antibody formulations
    Patent number: 10316095
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: June 11, 2019
    Assignee: Santarus, Inc.
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • Bromocriptine formulations
    Patent number: 10307421
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: June 4, 2019
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Anti-VLA1 (CD49A) antibody pharmaceutical compositions
    Patent number: 10160808
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: December 25, 2018
    Assignee: Santarus, Inc.
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • Bromocriptine Formulations
    Publication number: 20180263978
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: May 16, 2018
    Publication date: September 20, 2018
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Controlled-release solid dosage forms of mesalamine
    Patent number: 10071058
    Abstract: Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-release solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention relates to a method of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowel disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: September 11, 2018
    Assignee: Santarus, Inc.
    Inventors: Craig Michael Bowe, John Christopher Carter, Dana Elaine Moseson, Stephen Paul Levine
  • Bromocriptine formulations
    Patent number: 9993474
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 12, 2018
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20170340632
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: June 8, 2017
    Publication date: November 30, 2017
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 9700555
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: July 11, 2017
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20170020871
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: October 6, 2016
    Publication date: January 26, 2017
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 9522117
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: December 20, 2016
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20160038424
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: October 22, 2015
    Publication date: February 11, 2016
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • ANTI-VLA1 (CD49A) ANTIBODY PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160017043
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: February 14, 2013
    Publication date: January 21, 2016
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • Bromocriptine formulations
    Patent number: 9192576
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycerine control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: November 24, 2015
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • CONTROLLED-RELEASE SOLID DOSAGE FORMS OF MESALAMINE
    Publication number: 20150056275
    Abstract: Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-release solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention relates to a method of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowel disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
    Type: Application
    Filed: March 6, 2013
    Publication date: February 26, 2015
    Applicant: SANTARUS, INC.
    Inventors: Craig Michael Bowe, John Christopher Carter, Dana Elaine Moseson, Stephen Paul Levine
  • BROMOCRIPTINE FORMULATIONS
    Publication number: 20140187560
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycerine control in the treatment of type 2 diabetes.
    Type: Application
    Filed: November 22, 2013
    Publication date: July 3, 2014
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • ANTIBODY FORMULATIONS
    Publication number: 20140010827
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: August 30, 2013
    Publication date: January 9, 2014
    Applicant: SANTARUS, INC.
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly